Independence Bank Of Kentucky Vertex Pharmaceuticals Inc Transaction History
Independence Bank Of Kentucky
- $331 Million
- Q1 2024
A detailed history of Independence Bank Of Kentucky transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Independence Bank Of Kentucky holds 1,465 shares of VRTX stock, worth $711,975. This represents 0.18% of its overall portfolio holdings.
Number of Shares
1,465
Previous 70
1992.86%
Holding current value
$711,975
Previous $28,000
2085.71%
% of portfolio
0.18%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding VRTX
# of Institutions
1,625Shares Held
222MCall Options Held
1.35MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA25.6MShares$12.4 Billion1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$11 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY22MShares$10.7 Billion0.22% of portfolio
-
State Street Corp Boston, MA12MShares$5.84 Billion0.23% of portfolio
-
Alliancebernstein L.P. New York, NY7.1MShares$3.45 Billion1.08% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $125B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...